Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $12,000 | 4 | 72.1% |
| Food and Beverage | $3,828 | 133 | 23.0% |
| Travel and Lodging | $637.63 | 8 | 3.8% |
| Gift | $175.00 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $14,308 | 43 | $0 (2023) |
| ABBVIE INC. | $1,271 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $274.85 | 2 | $0 (2020) |
| Astellas Pharma US Inc | $142.36 | 6 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $110.34 | 6 | $0 (2024) |
| Baxter Healthcare | $59.46 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $58.80 | 2 | $0 (2024) |
| Memic Innovative Surgery Inc. | $54.00 | 1 | $0 (2022) |
| Avion Pharmaceuticals | $47.31 | 2 | $0 (2022) |
| Myovant Sciences Inc. | $38.05 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $358.56 | 13 | Astellas Pharma US Inc ($142.36) |
| 2023 | $304.83 | 17 | Sumitomo Pharma America, Inc. ($68.89) |
| 2022 | $508.71 | 24 | ABBVIE INC. ($167.06) |
| 2021 | $1,652 | 28 | Intuitive Surgical, Inc. ($1,443) |
| 2020 | $12,774 | 21 | Intuitive Surgical, Inc. ($12,587) |
| 2019 | $538.38 | 23 | AbbVie, Inc. ($447.03) |
| 2018 | $336.31 | 19 | AbbVie, Inc. ($336.31) |
| 2017 | $167.84 | 2 | AstraZeneca Pharmaceuticals LP ($150.39) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: HORMONE THERAPY | ||||||
| 12/05/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Biological | ||||||
| 11/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: HORMONE THERAPY | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Biological | ||||||
| 08/14/2024 | Baxter Healthcare | SEPRAFILM (Device) | Food and Beverage | In-kind items and services | $59.46 | General |
| Category: Surgical Care | ||||||
| 07/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Biological | ||||||
| 06/27/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Biological | ||||||
| 04/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Biological | ||||||
| 03/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Biological | ||||||
| 02/29/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Oncology | ||||||
| 11/22/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: HORMONE THERAPY | ||||||
| 10/12/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: HORMONE THERAPY | ||||||
| 10/10/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: SURGERY | ||||||
| 10/05/2023 | ASCEND THERAPEUTICS US, LLC | ESTROGEL (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Women's Health | ||||||
| 09/19/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.63 | General |
| 08/22/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: SURGERY | ||||||
| 07/25/2023 | CooperSurgical, Inc. | WALLACH Cryosurgical Equipment (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Not Applicable | ||||||
| 07/18/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: WOMENS HEALTH | ||||||
| 05/16/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $39.24 | General |
| Category: SURGERY | ||||||
| 05/16/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: SURGERY | ||||||
| 03/29/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: HORMONE THERAPY | ||||||
| 03/21/2023 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 241 | 263 | $112,478 | $28,834 |
| 2022 | 6 | 276 | 310 | $148,681 | $40,842 |
| 2021 | 7 | 339 | 397 | $156,763 | $40,888 |
| 2020 | 4 | 236 | 258 | $72,200 | $19,871 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 156 | $41,808 | $11,152 | 26.7% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 13 | 13 | $36,904 | $8,987 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $20,191 | $5,153 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,291 | $2,342 | 25.2% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 14 | 14 | $4,284 | $1,200 | 28.0% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 22 | 22 | $61,423 | $16,202 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 153 | $41,310 | $11,791 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $20,584 | $5,718 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $15,744 | $4,462 | 28.3% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 15 | 15 | $5,226 | $1,560 | 29.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 26 | $4,394 | $1,109 | 25.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 162 | 216 | $60,094 | $15,614 | 26.0% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 12 | 12 | $36,747 | $9,414 | 25.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $21,276 | $5,745 | 27.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 56 | 56 | $19,108 | $4,762 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 25 | $9,852 | $2,693 | 27.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 34 | $5,882 | $1,546 | 26.3% |
| 58100 | Biopsy of uterine lining | Office | 2021 | 12 | 12 | $3,804 | $1,114 | 29.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 127 | $29,210 | $8,101 | 27.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 81 | 81 | $26,730 | $7,276 | 27.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 37 | $12,321 | $3,350 | 27.2% |
| 58100 | Biopsy of uterine lining | Office | 2020 | 13 | 13 | $3,939 | $1,145 | 29.1% |
About Dr. Richard Friedman, M.D
Dr. Richard Friedman, M.D is a Obstetrics healthcare provider based in Burbank, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285641837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Friedman, M.D has received a total of $16,641 in payments from pharmaceutical and medical device companies, with $358.56 received in 2024. These payments were reported across 147 transactions from 22 companies. The most common payment nature is "Education" ($12,000).
As a Medicare-enrolled provider, Friedman has provided services to 1,092 Medicare beneficiaries, totaling 1,228 services with total Medicare billing of $130,435. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Obstetrics
- Location Burbank, CA
- Active Since 08/02/2006
- Last Updated 05/17/2016
- Taxonomy Code 207VX0000X
- Entity Type Individual
- NPI Number 1285641837
Products in Payments
- Da Vinci Surgical System (Device) $14,308
- Orilissa (Drug) $609.12
- ORILISSA (Drug) $299.86
- LYNPARZA (Drug) $274.85
- MYFEMBREE (Drug) $148.39
- Veozah (Drug) $142.36
- Lupron (Drug) $117.89
- ORIAHNN (Drug) $76.48
- LO LOESTRIN FE (Drug) $63.29
- SEPRAFILM (Device) $59.46
- Enhertu (Drug) $58.80
- Anovo Surgical System (Device) $54.00
- ELAHERE (Drug) $34.59
- ESTROGEL (Drug) $31.53
- Balcoltra (Drug) $26.50
- MYRISK (Device) $22.97
- THINPREP 2000 PROCESSOR (Device) $21.92
- Lenvima (Drug) $21.90
- NEXTSTELLIS (Drug) $20.98
- Vivjoa (Drug) $20.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.